Sustained-release microgranules containing Diltiazem as the active principle

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6228395
SERIAL NO

09091646

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Novel forms of sustained-release microgranules (LP) containing diltiazem are disclosed. The microgranules consist of a neutral granular carrier coated with an active layer including diltiazem or a pharmaceutically acceptable salt thereof as the active principle, a surfactant and a binder, and an outer layer providing sustained release of the active principle (layer LP).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CHANTILLY BIOPHARMA LLC3701 CONCORDE PARKWAY CHANTILLY VA 20151

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
DeBregeas, Patrice Paris, FR 16 235
LeDuc, Gerard Malesherbes, FR 16 235
Oury, Pascal Paris, FR 31 605
Suplie, Pascal Montaure, FR 33 534

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation